Organic compounds -- part of the class 532-570 series – Organic compounds – 9,10-seco-cyclopentanohydrophenanthrene ring system or...
Reexamination Certificate
2007-04-17
2007-04-17
Qazi, Sabiha N. (Department: 1616)
Organic compounds -- part of the class 532-570 series
Organic compounds
9,10-seco-cyclopentanohydrophenanthrene ring system or...
C514S167000
Reexamination Certificate
active
10459073
ABSTRACT:
Provided is a method of general applicability of epimerizing a vitamin-D analog having an asymmetric allylic carbon atom at the C-24 position. The method is of particular utility in making calcipotriene.
REFERENCES:
patent: 4594340 (1986-06-01), Partridge et al.
patent: 4866048 (1989-09-01), Calverley et al.
patent: 5401731 (1995-03-01), Calverley et al.
patent: 5665716 (1997-09-01), Kirsch et al.
patent: 6531459 (2003-03-01), Steinmeyer et al.
patent: WO 87/00834 (1987-02-01), None
Barnett et al., AN 1941:4546 HCAPLUS, DN 35:4546, Sterol group. XLI. A new epimerization process, Journal of the Chemical Society, Abstracts (1940) 1390-3.
Martin J. Calverley, “Synthesis of MC 903, A Biologically Active Vitamin D Metabolite Analogue,” Tetrahedron, vol. 43, No. 20(1987) pp. 4609-4619.
Effenberger Reinhard
Maymon Asher
Schwartz Anchel
Shapiro Evgeny
Kenyon & Kenyon LLP
Qazi Sabiha N.
Teva Pharmaceutical Industries Ltd.
LandOfFree
Epimerization of analogs of vitamin D does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Epimerization of analogs of vitamin D, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Epimerization of analogs of vitamin D will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3732382